Oshika T, Araie M
Eye Clinic, Tokyo Kosei Nenkin Hospital, Tokyo, Japan.
Nippon Ganka Gakkai Zasshi. 1990 Aug;94(8):762-8.
The effects of topically applied bunazosin hydrochloride, a recently developed highly selective alpha 1-adrenergic antagonist, on intraocular pressure, pupillary diameter, aqueous protein concentration, anterior chamber volume, aqueous flow rate and tonographic outflow facility were investigated in eight normal human volunteers. A single application of 0.1% bunazosin hydrochloride caused a significant unilateral reduction in the intraocular pressure from 30 minutes through 4 hours after the application, with a maximum decrease of 2.0 +/- 0.5mmHg (mean +/- SEM) below the contralateral control eyes at 2 hours post-application. Neither pupillary diameter, anterior chamber volume nor outflow facility was affected by the drug application. Both aqueous protein concentration measured with a flare-cell meter and aqueous flow rate determined by fluorophotometry were unaltered. The mechanism of intraocular pressure reduction appears to be an increase in uveoscleral outflow and/or a decrease in episcleral venous pressure.
在8名正常人类志愿者中,研究了局部应用最近开发的高选择性α1肾上腺素能拮抗剂盐酸布那唑嗪对眼压、瞳孔直径、房水蛋白浓度、前房容积、房水流量和眼压描记流出易度的影响。单次应用0.1%盐酸布那唑嗪后,在应用后30分钟至4小时内可导致单侧眼压显著降低,应用后2小时时,与对侧对照眼相比最大降低2.0±0.5mmHg(平均值±标准误)。药物应用对瞳孔直径、前房容积和流出易度均无影响。用闪光细胞仪测量的房水蛋白浓度和通过荧光光度法测定的房水流量均未改变。眼压降低的机制似乎是葡萄膜巩膜流出增加和/或巩膜静脉压降低。